The Anti-Diabetic Effect of Nano-Encapsulated Propolis from Apis mellifera on Type 2 Diabetes
Article Sidebar
Main Article Content
Abstract
Diabetes mellitus is viewed as a major disease and is among the most prevalent health problems globally. The goal of the present research was to evaluate the therapeutic efficiency of an ethanolic extract of Egyptian propolis (EEP) conjugated with chitosan polyacrylic (CS-PAA) nanoparticles against type 2 diabetes mellitus. Thirty Wistar rats were randomly categorized into 6 groups (5 animals/ group). Group I consisted of normal rats as a normal control. The remaining five groups were injected with streptozotocin (STZ), a diabetogenic agent, in order to induce diabetes. The experimental groups were treated for 4 consecutive weeks as follows: Group II included untreated diabetic rats, serving as a negative control. Group III consisted of diabetic rats treated with EEP. Group VI consisted of diabetic rats treated with Metformin. The findings of this work illustrated that no significant differences were noticed concerning the body weight of the treated groups compared to that of the normal control group. Blood glucose levels were significantly decreased in the diabetic rats treated with EEP and EEP encapsulated CS-PAA nanoparticles compared to the untreated diabetic rats. The results indicated that EEP encapsulated CS-PAA nanoparticles displayed a potential therapeutic effect against type 2 diabetes mellitus.
Keywords: diabetes mellitus; chitosan, polyacrylic acid; propolis; body weight
*Corresponding author: Tel.: (+20) 100 494 2997
E-mail: sarah.hegazy@sci.asu.edu.eg
Article Details
Copyright Transfer Statement
The copyright of this article is transferred to Current Applied Science and Technology journal with effect if and when the article is accepted for publication. The copyright transfer covers the exclusive right to reproduce and distribute the article, including reprints, translations, photographic reproductions, electronic form (offline, online) or any other reproductions of similar nature.
The author warrants that this contribution is original and that he/she has full power to make this grant. The author signs for and accepts responsibility for releasing this material on behalf of any and all co-authors.
Here is the link for download: Copyright transfer form.pdf
References
Rivera-Yañez, N., Rodriguez-Canales, M., Nieto-Yañez, O., Jimenez-Estrada, M., Ibarra-Barajas, M., Canales-Martinez, M.M. and Rodriguez-Monroy, M.A., 2018. Hypoglycaemic and antioxidant effects of propolis of Chihuahua in a model of experimental diabetes. Evidence-based Complementary and Alternative Medicine, 2018, https://doi.org/10.1155/ 2018/4360356
El-Awady, M.S., El-Agamy, D.S., Suddek, G.M. and Nader, M.A., 2014. Propolis protects against high glucose-induced vascular endothelial dysfunction in isolated rat aorta. Journal of Physiology and Biochemistry, 70(1), 247-254.
Al-Hariri, M.T., 2011. Propolis and its direct and indirect hypoglycemic effect. Journal of Family and Community Medicine, 18(3), 152-154.
Zhang, J., Cao, X., Ping, S., Wang, K., Shi, J., Zhang, C., Zheng, H. and Hu, F., 2015. Comparisons of ethanol extracts of Chinese propolis (poplar type) and poplar gums based on the antioxidant activities and molecular mechanism. Evidence-Based Complementary and Alternative Medicine, 2015, https://doi.org/10.1155/2015/307594
Ali, I., Lone, M.N., Suhail, M., Mukhtar, S.D. and Asnin, L., 2016. Advances in nanocarriers for anticancer drugs delivery. Current Medicinal Chemistry, 23(20), 2159-2187.
Rizvi, S.A.A. and Saleh, A.M., 2018. Applications of nanoparticle systems in drug delivery technology. Saudi Pharmaceutical Journal, 26(1), 64-70.
Pulgaron, E.R. and Delamater, A.M., 2014. Obesity and type 2 diabetes in children: Epidemiology and treatment. Current Diabetes Reports, 14(8), 508, https://doi.org/10.1007/s 11892-014-0508-y
U.S. Food and Drug Administration, 2019. Statement of Janet Woodcock, MD, Director of FDA's Center for Drug Evaluation and Research, on Impurities found in Diabetes Drugs Outside the U.S. States. Available at: https://www.fda.gov/news-events/press-announcements/ statement-janet-woodcock-md-director-fdas-center-drug-evaluation-and-research-impurities-found
Souza, E.A., Zaluski, R., Veiga, N. and Orsi, R.O., 2016. Effects of seasonal variations and collection methods on the mineral composition of propolis from Apis mellifera Linnaeus Beehives. Brazilian Journal of Biology, 76(2), 396-401.
Cunha, I.B.S., Sawaya, A.C.H.F., Caetano, F.M., Shimizu, M.T., Marcucci, M.C., Drezza, F.T., Povia, G.S. and Carvalho, P. de O., 2004. Factors that influence the yield and composition of Brazilian propolis extracts. Journal of the Brazilian Chemical Society, 15(6), 964-970.
Usman, U.Z., Bakar, A.B.A. and Mohamed, M., 2016. Phytochemical composition and activity against hyperglycaemia of Malaysian propolis in diabetic rats. Biomedical Research (India), 27(1), 46-51.
Braun, D., Cherdron, H., Rehahn, M., Ritter, H. and Voit, B., 2013. Polymer Synthesis: Theory and Practice. Berlin: Springer-Verlag.
Abou El Fadl, F.I., 2016. Synthesis and characterization of chitosan-poly(acrylamide-co-acrylic acid) magnetic nanocomposite hydrogels for use in catalysis. Russian Journal of Applied Chemistry, 89(10), 1673-1680.
Ray, D., Mohanta, G.P., Manavalan, R. and Sahoo, P.K., 2009. Synthesis and characterization of acrylic based copolymeric hydrogel nanoparticles: An approach to drug delivery. International Journal of ChemTech Research, 1(3), 627-633.
Wang, X., Chen, C., Huo, D., Qian, H., Ding, Y., Hu, Y. and Jiang, X., 2012. Synthesis of β-cyclodextrin modified chitosan-poly(acrylic acid) nanoparticles and use as drug carriers. Carbohydrate Polymers, 90(1), 361-369.
Kao, H.J., Lo, Y.L., Lin, H.R. and Yu, S.P., 2006. Characterization of pilocarpine-loaded chitosan/Carbopol nanoparticles. Journal of Pharmacy and Pharmacology, 58(2), 179-186.
Andrade, Â.L., Manzi, D. and Domingues, R.Z., 2006. Tetracycline and propolis incorporation and release by bioactive glassy compounds. Journal of Non-Crystalline Solids, 352(32-35), 3502-3507.
Zhu, A., Luo, X. and Dai, S., 2009. Chitosan-poly(acrylic acid) complex modified paramagnetic Fe3O4 nanoparticles for camptothecin loading and release. Journal of Materials Research, 24(7), 2307-2315.
Vatandoust, N., Rami, F., Salehi, A.R., Khosravi, S., Dashti, G., Eslami, G., Momenzaden, S. and Salehi, R., 2018. Novel high-fat diet formulation and streptozotocin treatment for induction of prediabetes and type 2 diabetes in rats. Advanced Biomedical Research, 7(1), 107, https://doi.org/10.4103/abr.abr_8_17
Dranse, H.J., Waise, T.M.Z., Hamr, S.C., Bauer, P.V., Abraham, M.A., Rasmussen, B.A. and Lam, T.T., 2018. Physiological and therapeutic regulation of glucose homeostasis by upper small intestinal PepT1-mediated protein sensing. Nature Communications, 9, 1118, https://doi.org/10.1038/s41467-018-03490-8
Zhang, F., Ye, C., Li, G., Ding, W., Zhou, W., Zhu, H., Chen. G., Luo, T., Guang, M. Liu, Y., Zhang, D., Zheng, S., Yang, J., Gu, Y., Xie, X. and Luo, M., 2003. The rat model of type 2 diabetic mellitus and its glycometabolism characters. Experimental Animals, 52(5), 401-407.
Sendrayaperumal, V., Pillai, S.I. and Subramanian, S., 2014. Design, synthesis and characterization of zinc-morin, a metal flavonol complex and evaluation of its antidiabetic potential in HFD-STZ induced type 2 diabetes in rats. Chemico-Biological Interactions, 219, 9-17.
Motyl, K. and McCabe, L.R., 2009. Streptozotocin, Type I diabetes severity and bone. Biological Procedures Online, 11, 296-315.
Al-Hariri, M., Eldin, T. and Al-Harb, M., 2016. Protective effect and potential mechanisms of propolis on streptozotocin-induced diabetic rats. Journal of Taibah University Medical Sciences, 11(1), 7-12.
Usman, U.Z., Bakar, A.B.A. and Mohamed, M., 2018. Propolis improves pregnancy outcomes and placental oxidative stress status in streptozotocin-induced diabetic rats. BMC Complementary and Alternative Medicine, 18(1), 324, https://doi.org.//10.1186/s12906-018-2391-6
Huang, S., Zhang, C.-P., Wang, K., Li, G. and Hu, F.-L., 2014. Recent advances in the chemical composition of propolis. Molecules, 19(12), 19610-19632.
Huang, X.-Y, Guo, X.-L, Luo, H.-L, Fang, X.-W, Zhu, T.-G, Zhang, X.-L., Chen, H.W. and Luo, L.-P., 2015. Fast differential analysis of propolis using surface desorption atmospheric pressure chemical ionization mass spectrometry. International Journal of Analytical Chemistry, 2015, https://doi.org/10.1155/2015/176475
Cevher, E., Salomon, S.K., Makrakis, A., Li, X.W., Brocchini, S. and Alpar, H.O., 2015. Development of chitosan-pullulan composite nanoparticles for nasal delivery of vaccines: Optimisation and cellular studies. Journal of Microencapsulation, 32(8), 755-768.
Seven, P.T., Seven, I., Baykalir, B.G., Mutlu, S.I. and Salem, A.Z.M., 2018. Nanotechnology and nano-propolis in animal production and health: an overview. Italian Journal of Animal Science, 17(4), 921-930.
Omidirad, R., Rajabi, F.H. and Farahani, B.V., 2013. Preparation and in vitro drug delivery response of doxorubicin loaded PAA coated magnetite nanoparticles. Journal of the Serbian Chemical Society, 78(10), 1609-1616.
Guo, L., Liu, G., Hong, R.Y. and Li, H.Z., 2010. Preparation and characterization of chitosan poly(acrylic acid) magnetic microspheres. Marine Drugs, 8(7), 2212-2222.
Dounighi, N.M., Eskandari, R., Avadi, M.R., Zolfagharian, H., Sadeghi, A.M.M. and Rezayat, M., 2012. Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus eupeus scorpion venom as an antigen delivery system. The Journal of Venomous Animals and Toxins including Tropical Diseases, 18(1), 44-52.
Hussein, U., Hassan, N.Y., Elhalwagy, M.E.A., Zaki, A.R., Abubakr, H.O., Venkata, K.C.N., Jang, K.Y. and Bishayee, A., 2017. Ginger and propolis exert neuroprotective effects against monosodium glutamate-induced neurotoxicity in rats. Molecules, 22(11), 1928, https://doi.org/10.3390/molecules 22111928
Peres, R.S., Zmozinski, A.V., Brust, F.R., Macedo, A.J., Armelin, E., Alemán, C. and Ferreira, C.A., 2018. Multifunctional coatings based on silicone matrix and propolis extract. Progress in Organic Coatings, 123, 223-231.
El Rabey, H.A., Al-Seeni, M.N. and Bakhashwain, A.S., 2017. The antidiabetic activity of Nigella sativa and propolis on streptozotocin-induced diabetes and diabetic nephropathy in male rats. Evidence-Based Complementary and Alternative Medicine, 2017, https://doi.org/ 10.1155/2017/5439645
Holmes, A., Coppey, L.J., Davidson, E.P. and Yorek, M.A., 2015. Rat models of diet-induced obesity and high fat/low dose streptozotocin type 2 diabetes: Effect of reversal of high fat diet compared to treatment with Enalapril or Menhaden oil on glucose utilization and neuropathic endpoints. Journal of Diabetes Research, 2015, https://doi.org/10.1155/2015/307285
Li, Y., Chen, M., Xuan, H. and Hu, F., 2012. Effects of encapsulated propolis on blood glycemic control, lipid metabolism, and insulin resistance in type 2 diabetes mellitus rats. Evidence-Based Complementary and Alternative Medicine, 2012, https://doi.org/10.1155/ 2012/981896
Kurek-Górecka, A., Rzepecka-Stojko, A., Górecki, M., Stojko, J., Sosada, M. and Świerczek-Zięba, G., 2013. Structure and antioxidant activity of polyphenols derived from propolis. Molecules, 19(1), 78-101.
Jadhav, R. and Puchchakayala, G., 2012. Hypoglycemic and antidiabetic activity of flavonoids: Boswellic acid, Ellagic acid, Quercetin, Rutin on streptozotocin-nicotinamide induced type 2 diabetic rats. International Journal of Pharmacy and Pharmaceutical Sciences, 4(2), 251-256.
Al-Hariri, M., Eldin, T.G., Abu-Hozaifa, B. and Elnour, A., 2011. Glycemic control and anti-osteopathic effect of propolis in diabetic rats. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 4, 377-384.
Mohammed, M.A,, Syeda, J.T.M., Wasan, K.M. and Wasan, E.K., 2017. An overview of chitosan nanoparticles and its application in non-parenteral drug delivery. Pharmaceutics, 9(4), 53, https//doi.org//10.3390/pharmaceutics9040053